Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 13:13:950826.
doi: 10.3389/fendo.2022.950826. eCollection 2022.

Gut microbiota is a potential goalkeeper of dyslipidemia

Affiliations

Gut microbiota is a potential goalkeeper of dyslipidemia

Lirong Lei et al. Front Endocrinol (Lausanne). .

Abstract

Dyslipidemia, as a common metabolic disease, could cause atherosclerosis, coronary heart disease, stroke and other cardio-cerebrovascular diseases. It is mainly caused by the interaction of genetic and environmental factors and its incidence has increased for several years. A large number of studies have shown that gut microbiota disorder is related to the development of dyslipidemia closely. Especially its metabolites such as short-chain fatty acids, bile acids and trimethylamine N-oxide affect dyslipidemia by regulating cholesterol balance. In this paper, we systematically reviewed the literature and used knowledge graphs to analyze the research trends and characteristics of dyslipidemia mediated by gut microbiota, revealing that the interaction between diet and gut microbiota leads to dyslipidemia as one of the main factors. In addition, starting from the destruction of the dynamic balance between gut microbiota and host caused by dyslipidemia, we systematically summarize the molecular mechanism of gut microbiota regulating dyslipidemia and provide a theoretical basis for the treatment of dyslipidemia by targeting the gut microbiota.

Keywords: bile acids; dyslipidemia; gut microbiota; short chain fatty acid; trimethylamine N-oxide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Research trend of the gut microbiota regulating dyslipidemia. (A) The number of published papers over the years includes the distribution of countries, (B) State relations, (C) Related keywords.
Figure 2
Figure 2
Schematic diagram of the interaction between diet, gut microbiota and lipid metabolism.
Figure 3
Figure 3
The gut microbiota regulates the pathway of dyslipidemia.

Similar articles

Cited by

References

    1. Cheng HY, Ning MX, Chen DK, Ma WT. Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol (2019) 10:607. doi: 10.3389/fimmu.2019.00607 - DOI - PMC - PubMed
    1. Alam A, Neish A. Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers (2018) 6(3):1539595. doi: 10.1080/21688370.2018.1539595 - DOI - PMC - PubMed
    1. Fukuda S, Ohno H. Gut microbiome and metabolic diseases. Semin Immunopathol (2014) 36(1):103–14. doi: 10.1007/s00281-013-0399-z - DOI - PubMed
    1. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, et al. . The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res (2010) 51(5):1101–12. doi: 10.1194/jlr.M002774 - DOI - PMC - PubMed
    1. Norris GH, Blesso CN. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. Nutr Rev (2017) 75(4):274–85. doi: 10.1093/nutrit/nux004 - DOI - PubMed

Publication types

LinkOut - more resources